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Background: Cervical radiculopathy caused by spondylotic foraminal stenosis may require surgical treatment. Surgical
options include anterior cervical foraminotomy and fusion or posterior cervical foraminotomy. Controversy remains
regarding the preferable surgical approach. Pertinent clinical evidence is limited to low-quality observational reports.
Therefore, treatment decisions are predominantly based on the individual surgeon’s preference and skill. The study
objective is to evaluate the efficacy and safety of posterior foraminotomy in comparison to anterior foraminotomy with
fusion for the treatment of spondylotic foraminal stenosis.
Methods/design: This is a multicenter randomized, controlled, parallel group superiority trial. A total of 88 adult
patients are allocated in a ratio of 1:1. Sample size and power calculations were performed to detect the minimal
clinically important difference of 14 points, with an expected standard deviation of 20 in the primary outcome
parameter, Neck Disability Index, with a power of 80%, based on an assumed maximal dropout rate of 20%. Secondary
outcome parameters include the Core Outcome Measures Index, which investigates pain, back-specific function, work
disability, social disability and patient satisfaction. Changes in physical and mental health are evaluated using the Short
Form-12 (SF-12) questionnaire. Moreover, radiological and health economic outcomes are evaluated. Follow-up is
performed 3, 6, 12, 24, 36, 48 and 60 months after surgery. Major inclusion criteria are cervical spondylotic foraminal
stenosis causing radiculopathy of C5, C6 or C7 and requiring decompression of one or two neuroforaminae. Study data
generation (study sites) and data storage, processing and statistical analysis (Department of Medical Statistics, Informatics
and Health Economics) are clearly separated. Data will be analyzed according to the intention-to-treat principle.
Discussion: The results of the ForaC study will provide surgical treatment recommendations for spondylotic foraminal
stenosis and will contribute to the understanding of its short- and long-term clinical and radiological postoperative
course. This will hopefully translate into improvements in surgical treatment and thus, clinical practice for spondylotic
foraminal stenosis.
Trial registration: Current Controlled Trials: ISRCTN82578069.
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Cervical radiculopathy is a clinical diagnosis defined by
the presence of sensory or motor deficits and complaints
caused by mechanical compression of the corresponding
cervical nerve root. Degenerative etiologies include disc
herniation, spinal canal stenosis and spondylotic foraminal
stenosis. Cervical radiculopathy remains a potentially
disabling disease with a significant impact on the patient’s
quality of life. Despite adequate conservative non-operative
therapy, a large number of patients will require surgical
treatment. Widely used options in this setting include
anterior cervical discectomy and fusion, cervical arthroplasty,
and posterior cervical foraminotomy. Moreover, a significant
increase in the frequency of surgical treatment has been
reported within the past decade. From 1999 to 2008, the
annual number of cervical discectomies with subsequent
fusion for degenerative disc diseases in the USA increased
by 67% [1]. In a larger retrospective survey, however, spon-
dylotic foraminal stenosis accounted for only approximately
20% of the surgical interventions in the degenerative
cervical spine [2]. Of these, around two-thirds were due to
unilateral foraminal stenosis, whereas one-third comprised
decompression of two or more stenotic foramina, empha-
sizing the multifocal nature of the disease. Although poster-
ior approaches to the cervical spine had been described
almost a decade earlier than the anterior approaches
[3,4], anterior discectomy has become the gold standard
for treating cervical degenerative disc diseases resulting in
encroachment of the central spinal canal [5-7]. For lateral
pathologies, however, there is still controversy regarding
the most adequate surgical approach. Most pertinent
literature in this matter consists of low-quality observa-
tional reports. Analyses of three comparative studies on
the treatment of cervical disc herniation yield inconclusive
results. One group of investigators observed an advantage
in the anterior approach in terms of short-term neuro-
logical recovery [8]. In turn, other authors have reported
significant benefits of the posterior approach regarding
the average time to return to unrestricted full duty of
military personnel [9]. A low-quality randomized controlled
trial comparing the two surgical approaches in the
treatment of acute cervical disc herniations did not
show any significant difference in outcome [10]. To
the best of our knowledge, prospective comparative data
primarily investigating spondylotic foraminal stenosis is
still lacking. Even non-comparative retrospective data
on spondylotic foraminal stenosis is scarce. Studies on
posterior foraminotomy reported good outcomes in
64% to 96% of patients and re-operation rates of around
4% to 7% [11-13]. The few studies exclusively investigating
anterior cervical foraminotomy and fusion reported 83%
to 91% good results and re-operation rates of 4% to 14%
[14,15]. Possible advantages of anterior cervical foraminot-
omy are direct access to remove anterior osteophytes andthe option of decompressing the foramina bilaterally using
a single surgical access. Moreover, the insertion of a cage
provides an additional indirect decompressive effect of the
foramina. This approach also offers the important option
of sagittal correction in cases with segmental kyphosis. A
potential disadvantage of anterior fusion might be the
precipitation of adjacent segment disease. In reviewing
409 anterior cervical fusions, Hilibrand and colleagues
[16] reported a relatively constant rate of symptomatic
adjacent segment disease of 2.9% per year, with 25.6% of
patients developing adjacent segment disease within
10 years of the operation and 7.5% of these patients
requiring a re-operation. By contrast, single-level posterior
foraminotomy for cervical radiculopathy displayed an
annual 0.7% rate of adjacent segment disease cumulating
to 6.7% at 10 years and a re-operation rate of 3.2% [17]. A
potential advantage of posterior cervical foraminotomy is
the maintenance of segmental motion in the majority of
treated segments, reducing the likelihood of adjacent
segment degeneration, as outlined. Two major concerns
with posterior foraminotomies are: (1) persistent neck and
shoulder pain secondary to muscle stripping performed
during the conventional open approach and (2) same-level
degeneration and kyphosis secondary to partial resection
of the facet joint. The latter issue is the subject of some
controversy. A frequently cited in-vitro study has shown
that non-physiological segmental mobility of the cervical
spine occurs when posterior foraminotomy involves
resection of more than 50% of a facet joint [18]. However,
other studies demonstrated that, even in cases of extensive
facetectomy, a cervical motion segment will remain stable
if all the anterior elements and one additional posterior
element, such as the interspinous and supraspinous
ligaments, are left intact [19,20]. A clinical study, supporting
these biomechanical results, reported favourable outcomes
in more than 90% of the patients five years after posterior
cervical foraminotomy including routine removal of 75% of
the facet joint [21].
The study objective is to evaluate the efficacy and safety
of posterior foraminotomy compared with anterior
foraminotomy with fusion for the treatment of spondylo-
tic foraminal stenosis. Both surgical approaches are well-
established techniques in clinical practice and can be
performed with comparable low risk. The surgical risk
profiles of the approaches differ according to local
anatomical features. Anterior surgery includes risks of
injury of cervical viscera, nerves (laryngeal recurrent
nerve, sympathetic chain) and vessels. Moreover, placement
of an intervertebral fusion cage might potentially result in
implant dislocation, pseudarthrosis and adjacent segment
disease. Specific risks of the posterior approach are
advancing degeneration of the affected level and pro-
gressive kyphotic deformity. Participation in the study
does not result in specific benefits for the patient.
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Study design
The ForaC study is a multicenter randomized, controlled,
parallel group superiority trial with 88 adult patients
allocated to the groups in a 1:1 ratio. The expected
enrolment time is 2 years, and the conclusion of the study
is estimated at 7 years. The primary study endpoint is the
difference in Neck Disability Index between treatment
groups at five years after intervention. As one of the
secondary study endpoints, the Core Outcome Measures
Index is applied to assess pain, back-specific function,
work disability, social disability and patient satisfaction.
Moreover, changes in physical and mental health are
assessed by the Short Form-12 (SF-12) questionnaire,
version 2. Adjacent level degeneration, segmental lordosis
and overall cervical sagittal alignment are determined
by flexion or extension X-rays and magnetic resonance
imaging. Pre-operative American Society of Anesthesiologists
grade staging might allow the identification of risk
factors. Neurological status and the quality and quantity of
current pain medication are documented. Operation timeTable 1 Primary and secondary outcome parameters
Primary outcome parameter Neck Disability Index at five years’ follow-up
Secondary outcome
parameters
Core Outcome Measures Index
Individual patient success at 12, 24, 36, 48 and
● Improvement of at least 17 in the Neck D
(adjustable according to results from own
● Pain relief, as defined by ≥20 mm improv
● Global outcome (1 or 2 on five-category L
● No opiates or opiate derivatives because
● Absence of symptomatic device failure an
Pain relief, as defined by ≥20 mm improvemen
Changes in physical and mental health defined
Form-12 (SF-12) version 2 questionnaire (Brazie
Modified Japanese Orthopedic Association sco
Adjacent level degeneration:
● By evidence of instability, defined as sagit
diameter) or sagittal plane rotation of >20
● By evidence of disc degeneration (Miyaza
resonance imaging
● Radiographic classification (Walraevens 0
● By occurrence of operation because of ad
Quantitative sensory testing
Segmental lordosis and overall cervical sagittal
Operative time
Length of hospital stay
Pain medication usage (including epidural inje
Return to work
Worker’s compensation
Direct and indirect societal costsand time of hospitalization are documented. Quantitative
sensory testing is performed to assess and quantify sensory
nerve function non-invasively. We also evaluate the direct
costs of hospital care and the indirect costs of follow-up
treatment outside the hospital. Costs of surgery and
hospitalization, including duration of inpatient treatment,
cost of nursing, costs of medication and physiotherapy, are
assessed after discharge from the hospital according to
internal cost-estimate lists from the hospital operator. In
addition, the indirect costs following discharge from
hospital (for example, including physiotherapy, rehabilita-
tion centres, pain medication, medical consulting) are
documented on a routing sheet. Each study participant will
receive such a routing sheet when leaving the hospital, with
instructions for documentation. Postoperative care is not
standardized in the study protocol and is to be performed
according to the standard of care for spondylotic foraminal
stenosis surgery at the participating sites. An external
orthosis is not used in either group. Primary and secondary
outcome parameters are outlined in more detail in Table 1.
Ethics approval was attained at the local research ethics60 month defined as:
isability Index (100 points) compared with baseline
minimal clinically important change results for Neck Disability Index).
ement on 100 mm visual analog for arm/shoulder pain
ikert scale)
of neck or arm pain
d re-operations at the index level
t on 100 mm visual analog scale for neck pain and arm or shoulder pain
as improvement of 15% in the overall score as captured by the Short
r 2005)
re and Nurick score
tal plane translation >3.5 mm (20% of vertebral body anterior-posterior
° based on standing flexion or extension X-rays
ki grade≥ IV) or osteochondrosis (Modic change type I) on magnetic
to 3)
jacent level disease
alignment
ctions and nerve block injections)
Table 2 Inclusion and exclusion criteria
Inclusion criteria Age between 18 and 80 years
Cervical spondylotic foraminal stenosis causing radiculopathy of C5, C6, or C7 and requiring decompression
of ≤2 neuroforaminae
Radiculopathy is defined as pain, paralysis or paresthesia in corresponding nerve root distribution areas of C5, C6,
or C7, and must include at least arm or shoulder pain with minimum of 30 mm on a 100 mm visual analog scale
Neck Disability Index score ≥30 out of 100
Unresponsive to non-operative treatment for six weeks or presence of progressive symptoms or signs of nerve
root compression in the face of conservative treatment
Spondylotic foraminal stenosis (determined by magnetic resonance imaging and computed tomography) at
treatment level correlating to primary symptoms
Appropriate candidate for treatment using either of:
● Anterior approach via ventral discectomy and fusion
● Posterior approach via foraminotomy, as described by Frykholm
Psychosocially, mentally, and physically able to fully comply with this protocol, including adhering to scheduled
visits, treatment plan, completing forms, and other study procedures
Personally signed and dated informed consent document prior to any study-related procedures, indicating that
the patient has been informed of all pertinent aspects of the trial
Clinical exclusion criteria Previous cervical spinal surgery at index level
Lumbar or thoracic spinal disease to the extent that surgical consideration is probable or anticipated within
6 month after the cervical surgical treatment
Upper extremity degenerative joint diseases (that is, shoulder) to the extent that:
● Surgical consideration is likely or anticipated within 6 month after the cervical surgical treatment
● Resulting pain is chronic (>3 month)
Axial neck pain in the absence of other symptoms of radiculopathy justifying the need for surgical intervention
Myelopathy
Neoplasia as the source of symptoms
Fixed or permanent neurological deficit unrelated to the cervical disc disease
Disease or conditions that preclude accurate clinical evaluation (for example, neuromuscular disorders)
Active or chronic infection, systemic or local
Systemic disease, including HIV, AIDS, or hepatitis
Active malignancy defined as a history of any invasive malignancy, except non-melanoma skin cancer, unless
the patient has been treated with curative intent and there have been no clinical signs or symptoms of the
malignancy for a minimum of 5 years
Paget’s disease, osteomalacia, or any other metabolic bone disease
Autoimmune disorder that impacts the musculoskeletal system (that is, lupus, rheumatoid arthritis, or
ankylosing spondylitis)
Acute episode or major mental illness (psychosis, major affective disorder or schizophrenia)
Physical symptoms without a diagnosable medical condition to account for the symptoms, which might
indicate symptoms of psychological rather than physical origin
Recent or current history of substance abuse (drugs, alcohol, narcotics, recreational drugs)
Anticipated long-term use of systemic steroid medications postoperatively
Radiological exclusion criteria Symptomatic spondylotic foraminal stenosis, considered for surgical intervention, with contralateral
asymptomatic spondylotic foraminal stenosis at the same level with equal or higher extent, as shown
by computed tomography
Cervical disc herniation or central canal stenosis causing radiculopathy or clinical myelopathy
Myelopathy, as shown by magnetic resonance imaging
Marked cervical instability on flexion or extension radiographs defined as:
● Translation >3 mm or
● Angulation >20°
Kyphotic segmental angulation >11° at treatment or adjacent levels
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Table 2 Inclusion and exclusion criteria (Continued)
VARIA
Patient is currently pursuing personal litigation related to spinal diseases
Prisoner or ward of the state
Patient has used another investigational drug or device within the 30 days prior to surgery
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This study complies with the World Medical Association
Declaration of Helsinki Ethical Principles for Medical
Research Involving Human Subjects, 2008.
Study population
The ForaC study aims to include patients who qualify
for decompression of ≤2 cervical neuroforamina by a
posterior or an anterior approach because of spondylotic
foraminal stenosis with radiculopathy. The target population
consists of patients with symptomatic spondylotic foraminal
stenosis without central canal stenosis who failed adequate
conservative or interventional therapy administered for a
minimum of six weeks. Radiculopathy is defined as pain,
paralysis or paresthesia in a specific nerve root distribution
at C5, C6 or C7. To recruit a rather homogeneous patient
population, patients with less severe symptomatology
(Neck Disability Index <30 points out of 100) are excluded.
Additionally, a radiologically (computed tomography and
magnetic resonance imaging) determined pathology at
treatment level needs to correlate with the primary
symptoms. To minimize risk factors for an unfavourable
outcome, patients with significant comorbidities need to
be excluded, as this may mask a difference in treatment
efficacy. Inclusion and exclusion criteria are outlined in
more detail in Table 2.
Informed consent is obtained from each participant.
Timetable
The timetable and visit plan is outlined in Table 3.
Investigational groups
Posterior foraminotomy
A midline skin incision is made extending across the
cervical motion segments of interest. The neck muscles
are subperiosteally dissected from the bone to expose the
lamina and a retractor system is applied. Once the facet
joint complex is exposed, a Kerrison punch is used to
remove some of the medial superior and inferior lamina to
access the spinal canal. A microscope is used for improved
illumination and visualization. A high-speed drill is then
used to thin the medial facet, centred over the joint. The
remaining bone overlying the nerve root is removed using
angled curettes and small Kerrison instruments. The nerve
hook is passed laterally out through the foramen to
confirm adequate neural decompression [4,21].Anterior foraminotomy
A transverse skin incision of 3 to 4 cm is made over
the cervical motion segments of interest. Access to
the cervical column is prepared by sharp and blunt
dissection, opening the superficial fascia at the medial
border of the sternocleidomastoid. Under distraction
of the target level, a discectomy is performed with
full exposure of the posterior longitudinal ligament.
Adjacent vertebral osteophytes are then resected with
complete foraminotomy on the affected side, with use of the
operating microscope. Direct visualization of the involved
nerve root from the axillae up to 3 mm distally is obtained.
The distraction is released, locking the intervertebral
cage firmly into position. A ventral locking plate is used
for additional stability, if deemed necessary [14].
Randomization
The allocation ratio is 1:1. The randomization code
will be generated independently from the clinical investi-
gators according to a random permuted blocks method
with varying block size. Randomization will be stratified
according to study centres. Statistical Software Stata 10.0
module Ralloc version 3.5.2 (Statacorp College Station,
TX, USA) will be used to generate the random code. An
independent statistician at the Department of Medical
Statistics, Informatics and Health Economics, Innsbruck
Medical University will administer the randomization
code (Figure 1).
Data management
Study data generation at the study sites is clearly separated
from data storage, processing and statistical analysis in the
Department of Medical Statistics, Informatics and Health
Economics (Figure 1). This requires a validated database
system programmed in a customized software pack-
age, which is provided by the Department of Medical
Statistics, Informatics and Health Economics of the
Medical University, Innsbruck. The system includes an
audit trail facility and will be used to define the database
structure, data entry, for handling data cleaning processes,
and for final data storage. Data evaluation takes place
by double entry of the data and manual and visual
evaluation of plausibility. After entry of all collected
data and clarification of all queries, the database will be
closed at the completion of the study. This performance
has to be documented.
Table 3 Visit plan
Pre-operation Intra-operation Post-operation,
3 days
Discharge 3 months
(±2 weeks)
6 months
(±1 month)
12 months
(±2 months)
24 months
(±2 months)
36 and 48
months
(±2 months)
60 months
(±2 months)
Informed consent × − − − − − − − − −
Pre-operative history × − − − − − − − − −
Randomization × − − − − − − − − −
American Society of Anesthesiologists
grade
× - − − − − − − − −
Operative detail − × − − − − − − − −
Clinical evaluation: neurological status,
pain medication consumption
× − × − × × × × × ×
Patient self-assessment: Neck Disability
Index, Core Outcome Measures Index,
Short Form-12 (SF-12) questionnaire
× − × − × × × × × ×
Quantitative sensory testing × − − − − × × − − −
Schedule of radiographic studies
Neutral, lateral and anterior-posterior × × − − × × × × − −
Flexion or extension × − − − × × × × − ×
Computed tomography × − × − − − − − − −
Magnetic resonance imaging × − − − × − − × − ×
Economic data collection
Hospitalization costs − − − × − − − − − −
Post-hospitalization costs − − − − × × × × × ×
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Figure 1 Data management and randomization process. Study data generation at the study sites is clearly separated from data storage,
processing and statistical analysis.
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The sample size calculation is based on the primary
endpoint of the study, the group difference in the
Neck Disability Index. A reduction in Neck Disability
Index score of 14 to 17 points out of 100 is considered to
be clinically meaningful [22,23]. Thus, 14 points were used
as the required difference between groups applicable
for the power calculations. Moreover, a group standard
deviation of 20 is assumed, based on results of comparable
previous trials [24,25]. A sample size calculation was
performed based on a two-group t test (GraphPad
StatMate Software, version 2.0); 35 patients per group are
required to detect a 14-point difference with 80% power on
a two-sided level of significance of 0.05. A loss to follow-up
of less than 20% was considered adequate for final calcula-
tion of sample size. Accordingly, the proposed sample size
amounts to 88 patients, that is, 44 patients in each group.
In case of non-normality of the Neck Disability Index, this
sample size is also sufficient to detect a difference of 14
points with a Mann-Whitney U test.
Statistical analysis
Endpoints will be analyzed as appropriate depending on
data distribution with a two-sided 0.05 level of significance.
Detailed descriptive statistics will be provided for the data
collected and 95% confidence intervals will be calculated
for all relevant estimates. Clinical follow-up data will
be analyzed by analysis of covariance (ANCOVA) or gener-
alized model alternatives for categorical or semiquantitative
data. Changes within the treatment groups over time as welldifferences between groups will be assessed simultaneously.
The primary analysis will follow the intention-to-treat
principle. All randomized patients with a complete prelim-
inary examination will be considered for inclusion into the
intention-to-treat population. Further sensitivity analysis
will be provided to evaluate robustness of the results with
regard to unexpected circumstances (for example, impact
of ‘cross-over’ patients who are not treated as randomized
but are required to be analyzed as randomized (intention-
to-treat principle) and centre effects. Secondary endpoints
will be analyzed in an exploratory manner at a two-sided
significance level of 5%. Safety and tolerability parameters
will be analyzed descriptively. Frequencies will be compared
by Chi-square or Fisher’s exact tests, as appropriate.
Analysis of time-dependent probabilities of critical events
will be performed using the Kaplan-Meier method.
Furthermore, multivariate event analyses will be performed
using Cox proportional hazard regression models. The last-
observation-carried-forward approach will be employed, in
order to perform an intention-to-treat analysis of the
primary efficacy endpoint in consideration of all randomized
patients. In addition, for the purpose of a supportive
sensitivity analysis, multiple imputation procedures will be
applied. Statistical analysis will be performed 12, 24, 36
and 60 months after completion of the last visit of the
study population at the specified time points.
Discussion
Owing to the high prevalence of spinal diseases and
increasing numbers of spinal interventions, spine research
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have facilitated large clinical trials on several frequent
spinal diseases. However, less common spinal diseases not
requiring special spinal implants and instruments have not
been subjected to well-designed clinical trials. This
phenomenon also applies to spondylotic foraminal stenosis,
representing approximately 20% of degenerative cervical
conditions requiring surgical intervention. The majority of
clinical data on spondylotic foraminal stenosis are more
than 10 years old. Beside the fact that there is a lack of
comparative data, it is also important to acknowledge that
clinical outcomes reported in these historic studies were
primarily based on rather crude rating scales of the patient’s
condition, and clinical follow-up was exclusively performed
by the treating physicians. With current standards, patient-
centred, well-validated outcome instruments are mandatory
and there is an urgent need for comparative data with vali-
dated modern outcome instruments to develop evidence-
based treatment recommendations. At this time, there are
no evidence-based guidelines on the most appropriate
surgical treatment strategy for cervical spondylotic
foraminal stenosis. Treatment decisions are determined
predominantly by the individual surgeon’s preference and
skill. The results of this study will provide surgical treat-
ment recommendations for spondylotic foraminal stenosis
and contribute to the understanding of its short- and
long-term clinical and radiological postoperative course.
This will hopefully be translated into an improvement of
surgical strategy and thus, clinical practice for spondylotic
foraminal stenosis.Trial status
The trial started in June 2013 with two sites in Austria,
the Department of Neurosurgery, Medical University
Innsbruck and the Department of Neurosurgery, LKH
Feldkirch. Two sites in Germany will join as soon as
local ethical approval is granted: the Department of
Neurosurgery, University Medical Center Mannheim,
Heidelberg University and the Spine Center, Hospital zum
Heiligen Geist Kempen. More sites might be recruited
during the enrolment phase.
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